Income Statement GE HealthCare Technologies Inc.

Equities

GEHC

US36266G1076

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 01:30:00 06/06/2026 am IST			5-day change	1st Jan Change
64.67 ^USD	+1.35%		+3.74%	-21.15%

04/06	GE HealthCare Receives FDA 510(k) Clearance For MIM Contour ProtégéAI+ 2.0	CI
04/06	GE HealthCare Gets FDA Clearance for AI-Powered Radiation Therapy Planning Software	MT

5cb7dd9eee1b7bf746.0fOI0C-BE_2fqW_nrEkt4K0Zge55sevsrqXG48gCsx8.i5v-vRzGI4f68yWTxSN82Z5r1LcT9aq4muy8gPxW_m2Fv-6AaeVDmf3OKg

Published financial data: GE HEALTHCARE TECHNOLOGIES INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	1.76TCr	1.83TCr	1.96TCr	1.97TCr	2.06TCr
Total Revenues	1.76TCr	1.83TCr	1.96TCr	1.97TCr	2.06TCr
Cost of Goods Sold, Total	1.04TCr	1.12TCr	1.16TCr	1.15TCr	1.24TCr
Gross Profit	717.4Cr	717.9Cr	792.2Cr	820.5Cr	824.7Cr
Selling General & Admin Expenses, Total	356.4Cr	362.1Cr	390.6Cr	386.8Cr	392.3Cr
R&D Expenses	82Cr	102.6Cr	120.5Cr	131.1Cr	126Cr
Other Operating Expenses, Total	438Cr	464.7Cr	511.1Cr	517.9Cr	518.3Cr
Operating Income	279.4Cr	253.2Cr	281.1Cr	302.6Cr	306.4Cr
Interest Expense, Total	-4Cr	-8.6Cr	-50Cr	-46Cr	-38Cr
Interest And Investment Income	3.4Cr	-	2.6Cr	-	4.1Cr
Net Interest Expenses	-60L	-8.6Cr	-48Cr	-46Cr	-34Cr
Income (Loss) On Equity Invest.	2.7Cr	1.3Cr	1.1Cr	80L	30L
Currency Exchange Gains (Loss)	-	-	-3.7Cr	-4.2Cr	-5.9Cr
Other Non Operating Income (Expenses)	6Cr	5.3Cr	3.8Cr	3.4Cr	70L
EBT, Excl. Unusual Items	287.5Cr	251.2Cr	234.4Cr	256.3Cr	267.5Cr
Gain (Loss) On Sale Of Investments	-	-	-	-	9.7Cr
Other Unusual Items	-	-	1.7Cr	1.8Cr	-40L
EBT, Incl. Unusual Items	287.5Cr	251.2Cr	236.1Cr	258.1Cr	276.8Cr
Income Tax Expense	60Cr	56Cr	74Cr	53Cr	61Cr
Earnings From Continuing Operations	227.5Cr	194.9Cr	161.8Cr	205Cr	215.4Cr
Earnings Of Discontinued Operations	1.8Cr	1.8Cr	-40L	-	-
Net Income to Company	229.3Cr	196.7Cr	161.4Cr	205Cr	215.4Cr
Minority Interest	-4.6Cr	-5.1Cr	-23Cr	-5.7Cr	-7Cr
Net Income - (IS)	224.7Cr	191.6Cr	138.5Cr	199.3Cr	208.4Cr
Net Income to Common Incl Extra Items	224.7Cr	191.6Cr	138.5Cr	199.3Cr	208.4Cr
Net Income to Common Excl. Extra Items	222.9Cr	189.8Cr	138.9Cr	199.3Cr	208.4Cr
Per Share Items
Net EPS - Basic	-	-	3.04	4.37	4.57
Basic EPS - Continuing Operations	-	-	3.05	4.37	4.57
Basic Weighted Average Shares Outstanding	-	-	46Cr	46Cr	46Cr
Net EPS - Diluted	-	-	3.03	4.34	4.55
Diluted EPS - Continuing Operations	-	-	3.04	4.34	4.55
Diluted Weighted Average Shares Outstanding	-	-	46Cr	46Cr	46Cr
Normalized Basic EPS	-	-	2.72	3.39	3.51
Normalized Diluted EPS	-	-	2.7	3.37	3.5
Dividend Per Share	-	-	0.12	0.12	0.14
Payout Ratio	-	-	2.96	2.76	3.07
Supplemental Items
EBITDA	341.9Cr	316.5Cr	342.1Cr	360.6Cr	364.2Cr
EBITA	319.4Cr	293.7Cr	317.3Cr	333.8Cr	335.5Cr
EBIT	279.4Cr	253.2Cr	281.1Cr	302.6Cr	306.4Cr
EBITDAR	360.4Cr	338.2Cr	365Cr	386.4Cr	389.1Cr
Total Revenues (As Reported)	1.76TCr	1.83TCr	1.96TCr	1.97TCr	2.06TCr
Effective Tax Rate - (Ratio)	20.87	22.41	31.47	20.57	22.18
Current Domestic Taxes	20Cr	49Cr	21Cr	7Cr	1.2Cr
Current Foreign Taxes	42Cr	32Cr	34Cr	41Cr	32Cr
Total Current Taxes	62Cr	82Cr	56Cr	48Cr	33Cr
Deferred Domestic Taxes	8.3Cr	-26Cr	8.2Cr	6.1Cr	15Cr
Deferred Foreign Taxes	-10Cr	70L	10Cr	-1.2Cr	13Cr
Total Deferred Taxes	-1.8Cr	-25Cr	18Cr	4.9Cr	28Cr
Normalized Net Income	175.09Cr	151.9Cr	123.6Cr	154.49Cr	160.19Cr
Interest on Long-Term Debt	-	-	62Cr	58Cr	54Cr
Non-Cash Pension Expense	10L	-1Cr	-30Cr	-32Cr	-21Cr
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	82Cr	102.6Cr	120.5Cr	131.1Cr	126Cr
Net Rental Expense, Total	18Cr	22Cr	23Cr	26Cr	25Cr
Imputed Operating Lease Interest Expense	164.44Cr	3.29Cr	10Cr	9.93Cr	7.65Cr
Imputed Operating Lease Depreciation	-145.94Cr	18Cr	13Cr	16Cr	17Cr
Stock-Based Comp., Other (Total)	-	-	11Cr	12Cr	13Cr
Total Stock-Based Compensation	-	-	11Cr	12Cr	13Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	56Cr	144Cr	249.4Cr	287.3Cr	449.2Cr
Total Cash And Short Term Investments	56Cr	144Cr	249.4Cr	287.3Cr	449.2Cr
Accounts Receivable, Total	366Cr	360.5Cr	384.1Cr	386.7Cr	426.1Cr
Other Receivables	-	29Cr	32Cr	41Cr	49Cr
Notes Receivable	9.9Cr	9.7Cr	9.7Cr	9Cr	9.5Cr
Total Receivables	375.9Cr	399.3Cr	425.4Cr	436.3Cr	484.9Cr
Inventory	194.6Cr	215.5Cr	196Cr	193.9Cr	223.4Cr
Prepaid Expenses	16Cr	16Cr	15Cr	19Cr	23Cr
Restricted Cash	-	50L	1Cr	1.6Cr	2Cr
Other Current Assets, Total	58Cr	56Cr	54Cr	52Cr	68Cr
Total Current Assets	700Cr	831.8Cr	941Cr	990.1Cr	1.25TCr
Gross Property Plant And Equipment	505.1Cr	530.2Cr	556.4Cr	563Cr	614.1Cr
Accumulated Depreciation	-281.6Cr	-298.8Cr	-306.4Cr	-308Cr	-304.9Cr
Net Property Plant And Equipment	223.5Cr	231.4Cr	250Cr	255Cr	309.2Cr
Long-term Investments	34Cr	32Cr	36Cr	37Cr	35Cr
Goodwill	1.29TCr	1.28TCr	1.29TCr	1.31TCr	1.35TCr
Other Intangibles, Total	184.7Cr	152Cr	125.3Cr	107.8Cr	113Cr
Accounts Receivable Long-Term	1.9Cr	8.6Cr	17Cr	21Cr	21Cr
Loans Receivable Long-Term	19Cr	20Cr	18Cr	18Cr	19Cr
Deferred Tax Assets Long-Term	128.7Cr	155Cr	447.4Cr	447.4Cr	449.1Cr
Deferred Charges Long-Term	7.7Cr	8.2Cr	-	-	20Cr
Other Long-Term Assets, Total	42Cr	34Cr	117.8Cr	118.6Cr	125.1Cr
Total Assets	2.63TCr	2.75TCr	3.25TCr	3.31TCr	3.69TCr
Liabilities
Accounts Payable, Total	254Cr	294.4Cr	294.7Cr	302.2Cr	325Cr
Accrued Expenses, Total	-	133.3Cr	198.6Cr	203.5Cr	223Cr
Short-term Borrowings	-	-	100.6Cr	20L	60L
Current Portion of Long-Term Debt	60L	1.5Cr	-	150Cr	50Cr
Current Portion of Leases	-	10Cr	11Cr	12Cr	13Cr
Current Income Taxes Payable	-	-	-	28Cr	32Cr
Unearned Revenue Current, Total	186.4Cr	189.6Cr	191.8Cr	194.3Cr	209.5Cr
Other Current Liabilities	235.1Cr	90Cr	101.4Cr	66Cr	56Cr
Total Current Liabilities	676.1Cr	719.1Cr	898.1Cr	955.3Cr	910.5Cr
Long-Term Debt	3.1Cr	823.4Cr	843.6Cr	744.9Cr	949.5Cr
Long-Term Leases	-	28Cr	31Cr	31Cr	33Cr
Unearned Revenue Non Current	-	63Cr	70Cr	69Cr	80Cr
Pension & Other Post Retirement Benefits	75Cr	55Cr	578.2Cr	558.3Cr	545.3Cr
Deferred Tax Liability Non Current	38Cr	37Cr	6.8Cr	5.6Cr	19Cr
Other Non Current Liabilities	148.4Cr	69Cr	86Cr	80Cr	93Cr
Total Liabilities	941.2Cr	1.79TCr	2.51TCr	2.44TCr	2.63TCr
Common Stock, Total	1.77TCr	1.12TCr	50L	50L	50L
Additional Paid In Capital	-	-	649.3Cr	658.3Cr	670.7Cr
Retained Earnings	-	-	132.6Cr	326.2Cr	528.1Cr
Treasury Stock	-	-	-	-2.5Cr	-22Cr
Comprehensive Income and Other	-103.7Cr	-187.8Cr	-69Cr	-137.9Cr	-138.9Cr
Total Common Equity	1.67TCr	935.7Cr	713.3Cr	844.6Cr	1.04TCr
Minority Interest	24Cr	24Cr	18Cr	21Cr	22Cr
Total Equity	1.69TCr	959.2Cr	731Cr	865.2Cr	1.06TCr
Total Liabilities And Equity	2.63TCr	2.75TCr	3.25TCr	3.31TCr	3.69TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	-	45Cr	46Cr	46Cr	46Cr
ECS Total Common Shares Outstanding	-	-	46Cr	46Cr	46Cr
Book Value / Share	-	-	15.67	18.48	22.77
Tangible Book Value	191.6Cr	-497.6Cr	-705.6Cr	-576.8Cr	-424Cr
Tangible Book Value Per Share	-	-	-15.5	-12.62	-9.3
Total Debt	3.7Cr	863.5Cr	986.3Cr	937.6Cr	1.05TCr
Net Debt	-52Cr	719.5Cr	736.9Cr	650.3Cr	597.1Cr
Debt Equivalent of Unfunded Proj. Benefit Obligation	39Cr	28Cr	353Cr	354.4Cr	345.8Cr
Debt Equivalent Oper. Leases	148Cr	173.6Cr	183.2Cr	206.4Cr	199.2Cr
Minority Interest, Total (Incl. Fin. Div)	24Cr	24Cr	18Cr	21Cr	22Cr
Equity Method Investments, Total	34Cr	32Cr	36Cr	37Cr	35Cr
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	90Cr	105.3Cr	96Cr	92Cr	100.2Cr
Inventories - Work In Process, Total	10Cr	9.1Cr	9.1Cr	9.2Cr	9.5Cr
Inventories - Finished Goods, Total	94Cr	101.1Cr	91Cr	93Cr	113.7Cr
Land - (BS)	7.7Cr	7Cr	7Cr	6.6Cr	14Cr
Buildings, Total	175.6Cr	188.9Cr	195.6Cr	194.3Cr	214Cr
Machinery, Total	246.6Cr	254.1Cr	261.7Cr	270.4Cr	287.3Cr
Full Time Employees	51T	50T	51T	53T	54T
Accumulated Allowance for Doubtful Accounts (Supple)	11Cr	9.1Cr	9.8Cr	10Cr	10Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	224.7Cr	191.6Cr	138.5Cr	199.3Cr	208.4Cr
Depreciation & Amortization - CF	22Cr	23Cr	25Cr	27Cr	29Cr
Amortization of Goodwill and Intangible Assets - (CF)	40Cr	40Cr	36Cr	31Cr	29Cr
Depreciation & Amortization, Total	62Cr	63Cr	61Cr	58Cr	58Cr
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-9.7Cr
Stock-Based Compensation (CF)	-	-	11Cr	12Cr	13Cr
Net Cash From Discontinued Operations	-	-2.1Cr	-	-40L	-
Other Operating Activities, Total	1.3Cr	-32Cr	-20Cr	-61Cr	-35Cr
Change In Accounts Receivable	-131.3Cr	-45Cr	-18Cr	-18Cr	-28Cr
Change In Inventories	-44Cr	-40Cr	11Cr	-8.1Cr	-14Cr
Change In Accounts Payable	26Cr	48Cr	-1.3Cr	13Cr	9Cr
Change in Unearned Revenues	-2.1Cr	14Cr	2.6Cr	6.8Cr	8.1Cr
Change in Other Net Operating Assets	23Cr	14Cr	25Cr	-7.1Cr	-11Cr
Cash from Operations	160.7Cr	211.3Cr	210.1Cr	195.1Cr	198.7Cr
Capital Expenditure	-24Cr	-31Cr	-39Cr	-40Cr	-48Cr
Sale of Property, Plant, and Equipment	1.5Cr	40L	10L	-	-
Cash Acquisitions	-148.1Cr	-	-15Cr	-31Cr	-38Cr
Sale (Purchase) of Intangible assets	-60L	-	-	-	-
Investment in Marketable and Equity Securities, Total	-	-	-	-4Cr	-12Cr
Other Investing Activities, Total	-4.7Cr	-9.2Cr	-2.5Cr	-16Cr	-6.9Cr
Cash from Investing	-176.1Cr	-40Cr	-56Cr	-91Cr	-104.7Cr
Short Term Debt Issued, Total	-	90L	-	-	10L
Long-Term Debt Issued, Total	50L	819.8Cr	200.6Cr	100Cr	273.4Cr
Total Debt Issued	50L	820.7Cr	200.6Cr	100Cr	273.5Cr
Short Term Debt Repaid, Total	-70L	-	-1.2Cr	-	-
Long-Term Debt Repaid, Total	-1Cr	-30L	-86Cr	-141.8Cr	-176.7Cr
Total Debt Repaid	-1.7Cr	-30L	-87Cr	-141.8Cr	-176.7Cr
Issuance of Common Stock	-	-	-	3.3Cr	3.7Cr
Repurchase of Common Stock	-	-	-	-9.3Cr	-24Cr
Common Dividends Paid	-	-	-4.1Cr	-5.5Cr	-6.4Cr
Common & Preferred Stock Dividends Paid	-	-	-4.1Cr	-5.5Cr	-6.4Cr
Other Financing Activities, Total	-25Cr	-902.6Cr	-157.6Cr	-3.5Cr	-8.1Cr
Cash from Financing	-26Cr	-82Cr	-48Cr	-57Cr	62Cr
Foreign Exchange Rate Adjustments	-3.4Cr	-30L	-1Cr	-7.7Cr	6.6Cr
Miscellaneous Cash Flow Adjustments	-	-	-	-	-20L
Net Change in Cash	-45Cr	89Cr	105.5Cr	39Cr	162.2Cr
Supplemental Items
Cash Interest Paid	2.1Cr	-	57Cr	55Cr	52Cr
Cash Income Tax Paid (Refund)	-	-	47Cr	49Cr	43Cr
Levered Free Cash Flow	78Cr	184.08Cr	253.32Cr	186.49Cr	144.89Cr
Unlevered Free Cash Flow	80Cr	189.45Cr	284.89Cr	215.42Cr	168.7Cr
Change In Net Working Capital	132Cr	1.1Cr	-76Cr	4.1Cr	45Cr
Net Debt Issued / Repaid	-1.2Cr	820.4Cr	113.9Cr	-42Cr	97Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	6.91	5.88	5.86	5.77	5.47
Return on Total Capital	10.93	8.9	9.93	10.75	9.8
Return On Equity %	14.28	14.72	19.15	25.69	22.38
Return on Common Equity	14.21	14.59	16.85	25.59	22.14
Margin Analysis
Gross Profit Margin %	40.8	39.14	40.52	41.71	39.99
SG&A Margin	20.27	19.74	19.98	19.66	19.02
EBITDA Margin %	19.44	17.26	17.5	18.33	17.66
EBITA Margin %	18.16	16.01	16.23	16.97	16.27
EBIT Margin %	15.89	13.81	14.38	15.38	14.86
Income From Continuing Operations Margin %	12.94	10.63	8.28	10.42	10.44
Net Income Margin %	12.78	10.45	7.08	10.13	10.1
Net Avail. For Common Margin %	12.68	10.35	7.1	10.13	10.1
Normalized Net Income Margin	9.96	8.28	6.32	7.85	7.77
Levered Free Cash Flow Margin	4.43	10.04	12.96	9.48	7.02
Unlevered Free Cash Flow Margin	4.57	10.33	14.57	10.95	8.18
Asset Turnover
Asset Turnover	0.7	0.68	0.65	0.6	0.59
Fixed Assets Turnover	7.93	8.06	8.12	7.79	7.31
Receivables Turnover (Average Receivables)	5.85	5.27	5.25	5.1	5.08
Inventory Turnover (Average Inventory)	5.88	5.44	5.65	5.88	5.93
Short Term Liquidity
Current Ratio	1.04	1.16	1.05	1.04	1.37
Quick Ratio	0.62	0.74	0.74	0.75	1.02
Operating Cash Flow to Current Liabilities	0.24	0.29	0.23	0.2	0.22
Days Sales Outstanding (Average Receivables)	62.42	69.24	69.5	71.7	71.92
Days Outstanding Inventory (Average Inventory)	62.05	67.05	64.57	62.22	61.53
Average Days Payable Outstanding	79.73	88.02	94.02	95.43	90.51
Cash Conversion Cycle (Average Days)	44.75	48.28	40.06	38.49	42.94
Long Term Solvency
Total Debt/Equity	0.22	90.02	134.92	108.37	98.72
Total Debt / Total Capital	0.22	47.37	57.43	52.01	49.68
LT Debt/Equity	0.18	88.78	119.66	89.68	92.66
Long-Term Debt / Total Capital	0.18	46.72	50.93	43.04	46.63
Total Liabilities / Total Assets	35.78	65.17	77.48	73.85	71.28
EBIT / Interest Expense	69.85	29.44	5.57	6.54	8.04
EBITDA / Interest Expense	85.48	39.33	7.23	8.35	10.21
(EBITDA - Capex) / Interest Expense	79.42	35.72	6.46	7.48	8.95
Total Debt / EBITDA	0.01	2.55	2.7	2.43	2.69
Net Debt / EBITDA	-0.15	2.13	2.02	1.68	1.53
Total Debt / (EBITDA - Capex)	0.01	2.81	3.02	2.71	3.07
Net Debt / (EBITDA - Capex)	-0.16	2.34	2.26	1.88	1.75
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	2.45	4.3	6.6	0.61	4.84
Gross Profit, 1 Yr. Growth %	6.01	0.07	10.35	3.57	0.51
EBITDA, 1 Yr. Growth %	2.18	-7.43	10.35	5.41	0.47
EBITA, 1 Yr. Growth %	2.24	-8.05	10.48	5.2	-0.06
EBIT, 1 Yr. Growth %	2.87	-9.38	13.94	7.65	0.62
Earnings From Cont. Operations, 1 Yr. Growth %	10.54	-14.33	-16.98	26.7	5.07
Net Income, 1 Yr. Growth %	-83.77	-14.73	-27.71	43.9	4.57
Normalized Net Income, 1 Yr. Growth %	6.58	-13.24	-16.39	24.99	2.9
Diluted EPS Before Extra, 1 Yr. Growth %	-	-	-27.27	42.76	4.84
Accounts Receivable, 1 Yr. Growth %	55.41	7.48	6.55	0.68	10.19
Inventory, 1 Yr. Growth %	22.08	10.74	-9.05	-1.07	15.21
Net Property, Plant and Equip., 1 Yr. Growth %	1.5	3.53	8.04	2	21.25
Total Assets, 1 Yr. Growth %	8.59	4.68	17.85	1.96	11.54
Tangible Book Value, 1 Yr. Growth %	52.55	-359.71	41.8	-18.25	-26.49
Common Equity, 1 Yr. Growth %	13.09	-43.82	-23.77	18.41	22.89
Cash From Operations, 1 Yr. Growth %	-4.74	31.49	-0.57	-7.14	1.85
Capital Expenditures, 1 Yr. Growth %	2.11	28.1	24.84	3.62	20.2
Levered Free Cash Flow, 1 Yr. Growth %	-	173.82	35.68	-26.38	-22.8
Unlevered Free Cash Flow, 1 Yr. Growth %	-	171.71	48.31	-24.38	-22.12
Dividend Per Share, 1 Yr. Growth %	-	-	-	4.17	12
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	2.82	3.37	5.44	3.56	2.71
Gross Profit, 2 Yr. CAGR %	4.67	3	5.08	6.91	2.03
EBITDA, 2 Yr. CAGR %	11	-2.74	0.03	7.85	2.92
EBITA, 2 Yr. CAGR %	11.92	-3.04	-0.33	7.81	2.55
EBIT, 2 Yr. CAGR %	14.91	-3.45	0.3	10.75	4.09
Earnings From Cont. Operations, 2 Yr. CAGR %	16.33	-2.68	-15.67	2.56	15.38
Net Income, 2 Yr. CAGR %	21.43	-62.8	-21.49	1.99	22.67
Normalized Net Income, 2 Yr. CAGR %	17.05	-3.84	-15.98	2.22	13.36
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	-21.31	1.9	22.34
Accounts Receivable, 2 Yr. CAGR %	-	23.72	7.01	3.57	5.33
Inventory, 2 Yr. CAGR %	-	16.27	0.36	-5.14	6.76
Net Property, Plant and Equip., 2 Yr. CAGR %	-	2.51	5.76	4.98	11.21
Total Assets, 2 Yr. CAGR %	-	6.61	11.07	9.61	6.64
Tangible Book Value, 2 Yr. CAGR %	-	99.04	91.9	7.66	-22.48
Common Equity, 2 Yr. CAGR %	-	-20.29	-34.56	-4.99	20.63
Cash From Operations, 2 Yr. CAGR %	-10.11	11.92	14.34	-3.91	-2.75
Capital Expenditures, 2 Yr. CAGR %	-4.08	14.37	24.92	13.73	11.6
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	84	-0.06	-24.19
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	91.94	5.9	-23.19
Dividend Per Share, 2 Yr. CAGR %	-	-	-	-	8.01
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	3.31	4.44	3.81	3.99
Gross Profit, 3 Yr. CAGR %	-	3.11	5.39	4.58	4.73
EBITDA, 3 Yr. CAGR %	-	4.48	0.74	1.79	5.52
EBITA, 3 Yr. CAGR %	-	4.82	0.52	1.48	5.32
EBIT, 3 Yr. CAGR %	-	6.17	1.15	2.69	7.49
Earnings From Cont. Operations, 3 Yr. CAGR %	-	5.05	-7.71	-3.41	3.39
Net Income, 3 Yr. CAGR %	-	7.93	-53.58	-3.92	2.84
Normalized Net Income, 3 Yr. CAGR %	-	5.93	-9.05	-4.09	2.71
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-	-4.03	2.87
Accounts Receivable, 3 Yr. CAGR %	-	-	17.71	4.86	5.73
Inventory, 3 Yr. CAGR %	-	-	7.13	-0.12	1.21
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	4.32	4.49	10.14
Total Assets, 3 Yr. CAGR %	-	-	10.23	7.94	10.25
Tangible Book Value, 3 Yr. CAGR %	-	-	77.77	44.39	-5.2
Common Equity, 3 Yr. CAGR %	-	-	-21.47	-20.26	3.52
Cash From Operations, 3 Yr. CAGR %	-	2.04	7.59	6.68	-2.03
Capital Expenditures, 3 Yr. CAGR %	-	5.63	17.76	17.37	15.85
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	35.58	-8.11
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	40.71	-4.24
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	3.41	3.74
Gross Profit, 5 Yr. CAGR %	-	-	-	4.62	4.04
EBITDA, 5 Yr. CAGR %	-	-	-	5.38	1.71
EBITA, 5 Yr. CAGR %	-	-	-	5.53	1.44
EBIT, 5 Yr. CAGR %	-	-	-	7.42	2.44
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	4.05	0.92
Net Income, 5 Yr. CAGR %	-	-	-	5.51	-31.53
Normalized Net Income, 5 Yr. CAGR %	-	-	-	3.87	-0.5
Accounts Receivable, 5 Yr. CAGR %	-	-	-	-	12.59
Inventory, 5 Yr. CAGR %	-	-	-	-	6.98
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	-	7.02
Total Assets, 5 Yr. CAGR %	-	-	-	-	8.78
Tangible Book Value, 5 Yr. CAGR %	-	-	-	-	27.55
Common Equity, 5 Yr. CAGR %	-	-	-	-	-6.76
Cash From Operations, 5 Yr. CAGR %	-	-	-	-0.39	3.33
Capital Expenditures, 5 Yr. CAGR %	-	-	-	8.8	15.26